| abstract |
The present invention is directed to the use of the combination of the peptide compounds Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg- Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 (P518) and Phe-Phe-Val-Ala-Pro as a therapeutic combination for prophylaxis and/or treatment of cancer, a heart and vascular disease, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, or an autoimmune disease. |